(ACA) Arcosa - Overview
Stock: Aggregates, Wind Towers, Utility Poles, Barges, Shoring
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.21% |
| Yield on Cost 5y | 0.33% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 96.3% |
| Payout Ratio | 6.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.8% |
| Relative Tail Risk | -5.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.59 |
| Alpha | 5.51 |
| Character TTM | |
|---|---|
| Beta | 1.055 |
| Beta Downside | 0.860 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.63% |
| CAGR/Max DD | 0.82 |
Description: ACA Arcosa January 10, 2026
Arcosa Inc. (NYSE: ACA) is a Dallas-based provider of infrastructure-related products and services, organized into three operating segments: Construction Products (aggregates, specialty materials, and site-support equipment), Engineered Structures (utility, wind-tower, traffic, lighting, and telecom structures sold to contractors and government agencies), and Transportation Products (inland barges, barge covers, winches, and marine hardware for commercial shippers and lessors). The firm was incorporated in 2018 and serves primarily U.S. construction, transportation, and energy markets.
Recent public filings show ACA generated roughly **$1.2 billion in revenue for FY 2023**, with an adjusted EBITDA margin near **12 %**, reflecting the relatively high-margin nature of its engineered-structures business. The company’s growth is closely tied to two macro-drivers: (1) the **U.S. bipartisan infrastructure law**, which is expected to channel $1.2 trillion in federal spending into roads, bridges, and utility upgrades over the next decade, and (2) **bulk-commodity shipping volumes**, which influence demand for its inland barges and marine hardware. Both drivers are subject to fiscal-policy timing and cyclical freight-rate fluctuations, respectively.
Assuming ACA can maintain its current cost-structure and capture a modest share of the projected infrastructure spend, its **free-cash-flow conversion** could exceed **15 % of revenue**, providing financial flexibility for acquisitions or dividend growth. However, the segment’s exposure to **aggregate price volatility** and **environmental-regulation compliance** introduces upside-down risk that could compress margins if input costs rise faster than pricing power.
For a deeper quantitative breakdown, you may find ValueRay’s ACA dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 148.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 3.45 > 1.0 |
| NWC/Revenue: 20.91% < 20% (prev 45.35%; Δ -24.44% < -1%) |
| CFO/TA 0.09 > 3% & CFO 469.3m > Net Income 148.6m |
| Net Debt (1.36b) to EBITDA (542.1m): 2.51 < 3 |
| Current Ratio: 2.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.0m) vs 12m ago 0.41% < -2% |
| Gross Margin: 21.61% > 18% (prev 0.20%; Δ 2142 % > 0.5%) |
| Asset Turnover: 60.21% > 50% (prev 57.06%; Δ 3.15% > 0%) |
| Interest Coverage Ratio: 2.65 > 6 (EBITDA TTM 542.1m / Interest Expense TTM 119.3m) |
Altman Z'' 2.17
| A: 0.12 (Total Current Assets 1.17b - Total Current Liabilities 579.7m) / Total Assets 5.05b |
| B: 0.18 (Retained Earnings 897.7m / Total Assets 5.05b) |
| C: 0.07 (EBIT TTM 315.8m / Avg Total Assets 4.70b) |
| D: 0.36 (Book Value of Equity 881.1m / Total Liabilities 2.47b) |
| Altman-Z'' Score: 2.17 = BBB |
Beneish M -2.96
| DSRI: 1.06 (Receivables 480.3m/396.4m, Revenue 2.83b/2.49b) |
| GMI: 0.92 (GM 21.61% / 19.84%) |
| AQI: 1.09 (AQ_t 0.35 / AQ_t-1 0.32) |
| SGI: 1.14 (Revenue 2.83b / 2.49b) |
| TATA: -0.06 (NI 148.6m - CFO 469.3m) / TA 5.05b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of ACA shares?
Over the past week, the price has changed by +8.97%, over one month by +15.04%, over three months by +26.44% and over the past year by +20.75%.
Is ACA a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 127.2 | 1.9% |
| Analysts Target Price | 127.2 | 1.9% |
| ValueRay Target Price | 155.4 | 24.6% |
ACA Fundamental Data Overview February 02, 2026
P/E Forward = 23.753
P/S = 1.9818
P/B = 2.1751
P/EG = 6.7234
Revenue TTM = 2.83b USD
EBIT TTM = 315.8m USD
EBITDA TTM = 542.1m USD
Long Term Debt = 1.57b USD (from longTermDebt, last quarter)
Short Term Debt = 9.30m USD (from shortTermDebt, last quarter)
Debt = 1.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.36b USD (from netDebt column, last quarter)
Enterprise Value = 6.98b USD (5.61b + Debt 1.58b - CCE 220.0m)
Interest Coverage Ratio = 2.65 (Ebit TTM 315.8m / Interest Expense TTM 119.3m)
EV/FCF = 22.18x (Enterprise Value 6.98b / FCF TTM 314.6m)
FCF Yield = 4.51% (FCF TTM 314.6m / Enterprise Value 6.98b)
FCF Margin = 11.11% (FCF TTM 314.6m / Revenue TTM 2.83b)
Net Margin = 5.25% (Net Income TTM 148.6m / Revenue TTM 2.83b)
Gross Margin = 21.61% ((Revenue TTM 2.83b - Cost of Revenue TTM 2.22b) / Revenue TTM)
Gross Margin QoQ = 24.05% (prev 22.54%)
Tobins Q-Ratio = 1.38 (Enterprise Value 6.98b / Total Assets 5.05b)
Interest Expense / Debt = 1.71% (Interest Expense 27.1m / Debt 1.58b)
Taxrate = 16.19% (14.1m / 87.1m)
NOPAT = 264.7m (EBIT 315.8m * (1 - 16.19%))
Current Ratio = 2.02 (Total Current Assets 1.17b / Total Current Liabilities 579.7m)
Debt / Equity = 0.61 (Debt 1.58b / totalStockholderEquity, last quarter 2.58b)
Debt / EBITDA = 2.51 (Net Debt 1.36b / EBITDA 542.1m)
Debt / FCF = 4.33 (Net Debt 1.36b / FCF TTM 314.6m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.16% (Net Income 148.6m / Total Assets 5.05b)
RoE = 5.96% (Net Income TTM 148.6m / Total Stockholder Equity 2.49b)
RoCE = 7.76% (EBIT 315.8m / Capital Employed (Equity 2.49b + L.T.Debt 1.57b))
RoIC = 6.37% (NOPAT 264.7m / Invested Capital 4.15b)
WACC = 7.96% (E(5.61b)/V(7.20b) * Re(9.80%) + D(1.58b)/V(7.20b) * Rd(1.71%) * (1-Tc(0.16)))
Discount Rate = 9.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.31%
[DCF Debug] Terminal Value 78.54% ; FCFF base≈237.1m ; Y1≈241.9m ; Y5≈266.6m
Fair Price DCF = 68.16 (EV 4.71b - Net Debt 1.36b = Equity 3.34b / Shares 49.0m; r=7.96% [WACC]; 5y FCF grow 1.84% → 2.90% )
EPS Correlation: 9.68 | EPS CAGR: -39.91% | SUE: -3.88 | # QB: 0
Revenue Correlation: 84.07 | Revenue CAGR: 11.99% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=+0.039 | Revisions Net=+1 | Analysts=6
EPS next Year (2026-12-31): EPS=4.76 | Chg30d=-0.086 | Revisions Net=+0 | Growth EPS=+12.9% | Growth Revenue=+5.5%